Table 1 Critical Appraisal research articles using the Joanna Briggs Institute (JBI) checklists (High quality: 80-100%; Medium quality: 50-80%; Low quality: < 50%)
From: Health system impacts of SARS-CoV − 2 variants of concern: a rapid review
Author, year | Pre-print (PP)/ Peer Review (PR) | Source | Average score | Adjust for PP or LE | Total Score (%) | Overall Quality |
|---|---|---|---|---|---|---|
Cohort Study Designa | ||||||
Bager, 2021 | PR | Lancet | 9.5 | N/A | 9.5 (86) | High |
Budhiraja, 2021 | PP | MedRxiv | 7.5 | −2 | 5.5 (50) | Medium |
Challen, 2021 | PR | BMJ | 10.5 | N/A | 10.5 (95) | High |
Cusinato, 2021 | PR | Infection | 10.5 | N/A | 10.5 (95) | High |
Dabrera, 2021 | PP | SSRN | 9.5 | −2 | 7.5 (68) | Medium |
Dennis, 2021 | PR | Critical Care Medicine | 9.5 | N/A | 9.5 (86) | High |
Erman, 2021 | PP | MedRxiv | 9.5 | −2 | 7.5 (68) | Medium |
Fisman, 2021 | PP | MedRxiv | 9 | −2 | 7 (64) | Medium |
Frampton, 2021 | PR | Lancet | 10.5 | N/A | 10.5 (95) | High |
Freitas B, 2021 | PP | MedRxiv | 8 | −2 | 6 (55) | Medium |
Grint, 2021 | PR | Clinical Infectious Diseases | 10.5 | N/A | 10.5 (95) | High |
Haas, 2021 | PR | Lancet | 10 | N/A | 10 (91) | High |
Havers, 2021 | PP | MedRxiv | 10.5 | −2 | 8.5 (77) | Medium |
Jassat, 2021 | PR | Lancet Global Health | 10.5 | N/A | 10.5 (95) | High |
Khedar, 2021 | PP | MedRxiv | 9 | −2 | 7 (64) | Medium |
Martin-Blondel, 2021 | PP | SSRN | 8.5 | −2 | 6.5 (59) | Medium |
Maslo, 2021 | PP | MedRxiv | 9.5 | −2 | 7.5 (68) | Medium |
McAllister, 2021 | PP | MedRxiv | 9 | -2 | 7 (64) | Medium |
Nyberg, 2021 | PR | BMJ Open | 11 | N/A | 11 (100) | High |
Ong, 2021 | PR | Clinical Infectious Diseases | 10 | N/A | 10 (91) | High |
Pascall, 2021 | PP | MedRxiv | 10 | -2 | 8 (73) | High |
Patone, 2021 | PR | Lancet | 9.5 | N/A | 9.5 (86) | High |
Peuch, 2021 | PP | Research Square | 10.5 | -2 | 8.5 (77) | Medium |
Stirrup, 2021 | PR | BMJ Open Respiratory Research | 11 | N/A | 11 (100) | High |
Swann, 2021 | PP | MedRxiv | 10 | -2 | 8 (73) | Medium |
Twohig, 2021 | PR | Lancet Infectious Diseases | 9.5 | N/A | 9.5 (86) | High |
Vassallo, 2021 | PR | Journal of Clinical Medicine | 8.5 | N/A | 8.5 (77) | Medium |
Veneti A, 2021 | PR | PLOS One | 9.5 | N/A | 9.5 (86) | High |
Veneti B, 2021 | PP | MedRxiv | 9 | -2 | 7 (88) | High |
Whittaker, 2021 | PR | Journal of Infection | 9 | N/A | 9 (82) | High |
Zavaski, 2021 | PP | Research Square | 9.5 | -2 | 7.5 (68) | Medium |
Cross-sectional Study Designb | ||||||
Adhikari, 2021 | PR | American Journal of Obstetrics & Gynecology | 4 | N/A | 4 (50) | Medium |
Agrawal, 2021 | PR | European Journal of Molecular & Clinical Medicine | 5 | N/A | 5 (63) | Medium |
AlQahtani, 2021 | PP | Research Square | 7 | -2 | 5 (63) | Medium |
Area, 2021 | PR | International Journal of Environmental Research and Public Health | 7 | N/A | 7 (88) | High |
Cetin, 2021 | PR | Acta Microbiologica et Immunologica Hungarica | 5.5 | N/A | 5.5 (69) | Medium |
Courjon, 2021 | PR | Nature | 6 | N/A | 6 (75) | Medium |
de Andrade, 2021 | PP | MedRxiv | 3.5 | -2 | 1.5 (19) | Low |
de Oliveira, 2021 | PP | MedRxiv | 3 | -2 | 1 (13) | Low |
Freitas A, 2021 | PP | SciELO pre-prints | 5.5 | -2 | 3.5 (44) | Low |
Funk, 2021 | PR | Eurosurveillance | 7 | N/A | 7 (88) | High |
Garvey, 2021 | LE | Journal of Infection | 7.5 | −1 | 6.5 (81) | High |
Graham, 2021 | PR | Lancet | 7 | N/A | 7 (88) | High |
Jablonska, 2021 | PP | MedRxiv | 5.5 | −2 | 3.5 (44) | Low |
Loconsole, 2021 | PR | Environmental Research and Public Health | 5 | N/A | 5 (63) | Medium |
Louis, 2021 | LE | Anaesthesia Critical Care & Pain Medicine | 5.5 | −1 | 4.5 (56) | Medium |
Martinez-Garcia, 2021 | PR | Microorganisms | 6 | N/A | 6 (75) | Medium |
Moore, 2021 | PP | MedRxiv | 3 | −2 | 1 (13) | Low |
Nonaka, 2021 | PR | International Journal of Infectious Diseases | 6.5 | N/A | 6.5 (81) | High |
Snell, 2021 | PP | MedRxiv | 6 | −2 | 4 (50) | Medium |
Takemoto, 2021 | PP | MedRxiv | 6 | −2 | 4 (50) | Medium |
Case Control Study Designc | ||||||
Abu-Raddad, 2021 | PR | Clinical Infectious Diseases | 7.5 | N/A | 7.5 (75) | Medium |